This content is machine translated Acute sinusitis: real-world study on first-line therapy Focusing on a rational therapeutic approach beyond antibiotics A retrospective cohort study published in 2024 analyzed data from patients with acute sinusitis in routine care. On the one hand, it was found that over 70% of patients received...…
View Post 6 min This content is machine translated DOAK optimization, ABC pathway and lessons learned from the FXI/XIa pipeline Stroke prevention for atrial fibrillation 2025 Atrial fibrillation is the most important treatable risk factor for ischemic strokes in 2025 – and at the same time an area where precision makes all the difference. The major...…
View Post 7 min This content is machine translated Prurigo nodularis and AD Effective itch relief through inhibition of the IL-31 signaling pathway The vicious circle of itching and scratching is a central element in both prurigo nodularis (PN) and atopic dermatitis (AD). Interleukin (IL)-31, often referred to as the “itch cytokine”, has...…
View Post 5 min This content is machine translated "Survey of Health, Ageing and Retirement in Europe" (SHARE) Analysis of polypharmacy in ≥65-year-olds The SHARE study is an international multidisciplinary longitudinal survey. The panel survey has been conducted approximately every other year for over 20 years. In an analysis published in 2025, data...…
View Post 6 min This content is machine translated From early intervention to individualization The new guidelines at a glance At the ESC Congress 2025, several guidelines and a consensus document were published or revised, which together will have a noticeable impact on everyday cardiology: a focused update on lipid...…
View Post 8 min This content is machine translated Mastocytosis Innovative pathogenesis-based therapeutic approaches in the pipeline The treatment of mastocytosis has undergone a paradigm shift in recent years. A deeper molecular understanding of the disease has paved the way from a purely symptomatic to a targeted,...…
View Post 11 min This content is machine translated COPD therapy Drug therapy – Update 2025 Chronic obstructive pulmonary disease ( COPD) is a chronic inflammatory multisystem disease caused primarily by inhaled noxious substances in combination with environmental factors and genetic predispositions. The presence of such...… CME-Test
View Post 8 min This content is machine translated GPP: from molecular principles to targeted therapy Therapeutic rationale for targeted IL-36 receptor inhibition The progress in the diagnosis and treatment of generalized pustular psoriasis (GPP) is remarkable. GPP has developed into a clearly defined, independent, IL-36-mediated autoinflammatory disease. Today, the high chronic disease...…
View Post 11 min This content is machine translated Shared decision making Participatory decision-making using the example of diets for type 1 diabetes Participatory decision-making (PEF for short) has established itself in recent decades as a desirable form of interaction between doctor and patient. The concept is primarily based on the ethical principles...… CME-Test
View Post 3 min This content is machine translated "Patients W.A.I.T Indicator" Access to medicines – how does Switzerland compare across Europe? According to a major international study, Switzerland has once again fallen behind other European countries in terms of access to new innovative medicines – from sixth to seventh place. Particularly...…
View Post 6 min This content is machine translated Migraine and vascular regulation CGRP-targeted migraine therapies for vascular risk patients Migraine is one of the most common neurological disorders and affects millions of people worldwide. With the development of CGRP-targeted therapies – monoclonal antibodies and Gepanten – the treatment of...…
